Skip to main content
. 2019 Jun 25;58(11):1355–1371. doi: 10.1007/s40262-019-00790-0

Fig. 5.

Fig. 5

Building a platform of evidence to enhance confidence in underlying PK mechanisms for a poorly soluble weak base with absorption predicted to be limited by precipitation. PPI proton pump inhibitor, PK pharmacokinetics, tox toxicology, SAD single ascending dose, MAD multiple ascending dose, Cmax maximum concentration, AUC area under the curve, tmax time to reach Cmax, BCS Biopharmaceutics Classification System